Cytoactus Therapeutics Private Limited - Company Profile

It is a paper private limited company based in Amberpet, Telangana, India, established in 2024.
2024 Amberpet, Telangana, India Active
Last Updated:
About Cytoactus Therapeutics Private Limited

Cytoactus Therapeutics Private Limited, a active private limited company, was established on 28 May 2024 in Amberpet, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001TS2024PTC185970. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.16 M.

Its leadership includes Nanda Kumar Kasha (Director), Gayathri Bathoju (Director), Andrew Paul O Keefe (Non- Individual Subscriber). It is based at 3-4-114/A Saichitra Nagar, Beside Hps Ramanthapur, Amberpet, Telangana, 500013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001TS2024PTC185970

  • Registration Number

    185970

  • Incorporation Date

    28 May 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.16 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.16 M
  • Company Age 1 Year 9 Months
Company report

Cytoactus Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cytoactus Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cytoactus Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Nanda Kumar Kasha Director 28 May 2024 Current
Gayathri Bathoju Director 28 May 2024 Current
Andrew Paul O Keefe Non- Individual Subscriber 28 May 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cytoactus Therapeutics.

Enhance accessibility to Cytoactus Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cytoactus Therapeutics revenue growth over time
Cytoactus Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cytoactus Therapeutics?

Unlock access to Cytoactus Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cytoactus Therapeutics?

Unlock and access historical data on people associated with Cytoactus Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cytoactus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytoactus Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cytoactus Therapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Nanda Kumar Kasha was appointed as a Director was appointed as a Director on 28 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    The activity Gayathri Bathoju was appointed as a Director was appointed as a Director on 28 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    Progress on Andrew Paul O Keefe was appointed as a Non- Individual Subscriber was appointed as a Non- Individual Subscriber on 28 May 2024 & has been associated with this company since 1 year 9 months . was documented.

  • Company Incorporation

    Progress on Cytoactus Therapeutics Private Limited was registered on 28 May 2024 with Roc Hyderabad & aged 1 year 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cytoactus Therapeutics Private Limited?

The CIN of Cytoactus Therapeutics Private Limited is U21001TS2024PTC185970.

Where is Cytoactus Therapeutics Private Limited headquartered?

Cytoactus Therapeutics Private Limited is headquartered at 3-4-114/A Saichitra Nagar, Beside Hps Ramanthapur, Amberpet, Telangana, 500013.

When was Cytoactus Therapeutics Private Limited incorporated?

Cytoactus Therapeutics Private Limited was incorporated on 28 May 2024.

Who are the current directors of Cytoactus Therapeutics Private Limited?

The current directors of Cytoactus Therapeutics Private Limited are

What is the primary industry of Cytoactus Therapeutics Private Limited?

The primary industry of Cytoactus Therapeutics Private Limited is Paper.

Is Cytoactus Therapeutics Private Limited a listed company?

Cytoactus Therapeutics Private Limited is unlisted.

What is the capital structure of Cytoactus Therapeutics Private Limited?

The authorized capital of Cytoactus Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.16 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available